# Treatment of Hypochondriasis With CBT and/or SSRI

> **NCT00339079** · PHASE1,PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 195 (actual)

## Conditions studied

- Hypochondriasis

## Interventions

- **DRUG:** Fluoxetine
- **BEHAVIORAL:** Cognitive Behavioral Therapy (CBT)
- **OTHER:** Supportive Therapy
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00339079
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2011-05
- **Final completion:** 2011-12
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00339079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00339079, "Treatment of Hypochondriasis With CBT and/or SSRI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00339079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*